BOLD
BOLD
NASDAQ · Biotechnology

Boundless Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$2.50
+0.05 (+2.04%)
As of Jun 30, 10:46 PM ET ·
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +387.6% upside
Low Target $8.12
Average Target $12.19
High Target $14.26
Current Price $2.50
Current
$2.50
Target
$12.19
$8.12 $12.19 avg $14.26
Scenario Analysis
Bear Case
$8.12
224.8%
Low target
Base Case
$12.19
+387.6%
Avg target
Bull Case
$14.26
+470.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.79
-10.4% from high
52-Week Low
$0.96
+160.1% from low
Target vs 52W High
$12.19
+336.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%